PDF file - Department of Health and Ageing
PDF file - Department of Health and Ageing
PDF file - Department of Health and Ageing
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
National Notifiable Diseases Surveillance System, 2004<br />
Annual report<br />
While Australia has one <strong>of</strong> the lowest rates <strong>of</strong><br />
tuberculosis (TB) in the world, the disease remains<br />
a public health problem in the overseas-born <strong>and</strong><br />
Indigenous communities. In 2004, 1,076 TB notifi cations<br />
were received by NNDSS, a rate <strong>of</strong> 5.4 cases<br />
per 100,000 population. There was an 8 per cent<br />
increase in the number <strong>of</strong> notifi cations in 2004<br />
compared to 2003. The notifi cation rates <strong>of</strong> TB were<br />
higher than the national average in the Northern<br />
Territory (14 cases per 100,000 population), <strong>and</strong><br />
the lowest rate occurred in Tasmania (2.3 cases per<br />
100,000 population).<br />
The highest incidence was reported in people<br />
born overseas (21.7 cases per 100,000 population)<br />
<strong>and</strong> Indigenous Australians (8.1 cases per<br />
100,000 population). By contrast the rate in the<br />
non-Indigenous Australian-born population was<br />
1.2 cases per 100,000 population. For more details<br />
see the tuberculosis 2004 annual report in this issue<br />
<strong>of</strong> Communicable Diseases Intelligence. 49<br />
Other communicable disease<br />
surveillance<br />
Laboratory Virology <strong>and</strong> Serology<br />
Reporting Scheme<br />
sentinel virology <strong>and</strong> serology laboratories around<br />
Australia. LabVISE provides data on diagnoses <strong>of</strong><br />
a number <strong>of</strong> infectious viruses, parasites <strong>and</strong> fungi.<br />
Interpretation <strong>of</strong> data from LabVISE is limited by<br />
uncertainties regarding its representativeness, lack<br />
<strong>of</strong> denominator data to calculate positivity rates, variable<br />
reporting coverage over time <strong>and</strong> lack <strong>of</strong> consistent<br />
case defi nitions. LabVISE has an important<br />
role in supplementing information <strong>of</strong> diseases under<br />
surveillance in NNDSS <strong>and</strong> in monitoring infectious<br />
agents that are not reported by other surveillance<br />
systems.<br />
In 2004, a total <strong>of</strong> 12 laboratories reported 26,218<br />
infectious agents to LabVISE. This represents a 14<br />
per cent increase in the number <strong>of</strong> reports received<br />
in 2004 compared to 2003 (Table 27). Most <strong>of</strong> the<br />
reports were from South Australia (30%), Queensl<strong>and</strong><br />
(27%) <strong>and</strong> Western Australia (16%) (Table 27).<br />
Sixty per cent (n=15,608) <strong>of</strong> all reports received<br />
by LabVISE were viral infectious agents, <strong>and</strong> the<br />
remaining 40 per cent (n=10,610) were bacterial<br />
or other infectious agents. Among viruses, herpes<br />
viruses (33.5%; 5,268) were the most commonly<br />
reported followed by ortho/paramyxoviruses (27%;<br />
4,124) which includes infl uenza, parainfl uenza <strong>and</strong><br />
respiratory syncytial viruses (Figure 67). Among<br />
non-viral infectious agents, Chlamydia trachomatis<br />
The Laboratory Virology <strong>and</strong> Serology Reporting<br />
Scheme (LabVISE) is a passive surveillance scheme<br />
based on voluntary reports <strong>of</strong> infectious agents from<br />
Figure 67. Reports <strong>of</strong> viral infections to the Laboratory Virology <strong>and</strong> Serology Reporting Scheme,<br />
2004, by viral group<br />
16.4%<br />
0.4%<br />
0.5%<br />
6.7%<br />
6.9%<br />
Measles, mumps <strong>and</strong><br />
rubella<br />
Hepatitis viruses<br />
Arboviruses<br />
Adenoviruses<br />
Herpes viruses<br />
Other DNA viruses<br />
Piconrnavirus family<br />
26.4%<br />
Ortho/paramyxoviruses<br />
Other RNA viruses<br />
33.8%<br />
6.2%<br />
2.7%<br />
CDI Vol 30 No 1 2006 73